J.G. Chemicals is India's largest zinc oxide manufacturer and largest zinc recycler, converting zinc dross and scrap into over 90 specialized grades of zinc oxide and zinc sulphate sold to tire, ceramic, pharma, specialty chemical and agricultural customers. Zinc oxide sits deep inside the tire value chain at 3.5-5% of compound weight but only 1-1.5% of tire cost, making it a mission-critical, low-cost-failure input. The competitive structure is an oligopoly with a fragmented tail: the top three-four Indian players control roughly 60-67% of the market, J.G. Chemicals alone holds over 30% share, and most of the 30-40 remaining regional players run below 5,000 tons per annum and cannot qualify for large accounts. Steady-state EBITDA margins of 10-11% look modest against a 25-30% exceptional threshold for manufacturers, but this is a converter business where the LME-linked pass-through model strips zinc price risk out of EBITDA, and the margin level has been stable across cycles, which is the more telling quality signal. Q1 FY27 delivered the best quarter in company history: revenue of INR315.7 crores, up 44.8% year-on-year, at an 11.5% EBITDA margin, showing the operating leverage already building ahead of new capacity.
The economics persist because of qualification and integration barriers that take years to replicate. Tire customer approval cycles run approximately five years, the Naidupeta plant is the only IATF-certified zinc oxide facility globally, and the company supplies every major Indian tire maker and nine of the world's top ten, with an internal survey showing more than 95% repeat orders. Its scrap-processing technology is internally developed IP built over two decades, and its 15-20 year supplier relationships made it the preferred customer for the majority of global zinc dross suppliers during the recent Middle East import freeze, when smaller players faced supply interruptions. This is not a commodity business despite the modest margin level; it is a scale-and-qualification business where the largest player converts recycled input into certified, customer-specific output that smaller rivals cannot economically match.
The inflection is capacity commissioning in Western India. Dahej Phase 1, a 15,000-17,000 ton per annum plant built for about INR100 crores with INR300-400 crores of Phase 1 revenue potential, is targeted for Q3 FY27 around November 2026, alongside a 5,000 ton Naidupeta brownfield addition, lifting capacity from roughly 70,000 MTA toward 90,000 MTA and beyond 1,15,000 MTA once both Dahej phases run. Management guides Dahej utilization at 50-60% in FY28 and 70-80% in FY29, with two of India's largest tire plants located 10-15 km from the site and a seeded ceramic customer base in the Morbi belt where current share is under 1% against a 15-20% target. The 18-24 month picture, roughly mid-2028, is a company with FY26 revenue of about INR973 crores compounding through FY27's 44.8% growth quarter, Dahej in its first full year at half utilization adding an estimated INR150-250 crores, non-rubber mix up from 18% toward the 30% target, and blended EBITDA margins moving from 11.5% toward 12-13% as higher-margin pharma, specialty and ceramic volumes scale.
Management's walk-talk record is strong on delivery but shows one slippage and one guidance retreat. The February 2026 call targeted Dahej commissioning in H1 FY27 with an internal Q2 goal; the August 2026 call moved this to Q3 FY27, the first timeline slip in four calls. Margin guidance was also walked down: the earlier promise of 13-14% within 2-3 years was reset in the guidance monitor to 10-11% near-term, before the latest call re-established 13-14% by FY29 and 14-15% over time. Against that, delivery has matched guidance elsewhere: Q2 FY26 EBITDA of 9.9% and H1 FY26 of 10.3% landed inside the guided band, the 70:30 mix shift is progressing on schedule from 10% to 18%, and the revenue-doubling-every-3-4-years glide path is intact with FY26 at INR973 crores versus INR857 crores in FY25. Capital allocation is conservative: the INR100 crores Dahej outlay is funded from internal accruals, cash exceeds INR150 crores, no debt or dilution is planned, and each INR200 crores of turnover needs roughly INR60-65 crores of working capital at a 100-day cycle.
The quantified path: capacity near 90,000 MTA from Q3 FY27, Dahej at 50-60% utilization through FY28 and 70-80% by FY29, revenue approaching INR1,300-1,400 crores by FY29, and EBITDA margins of 13-14% by FY29, implying EBITDA of roughly INR170-190 crores versus INR97.9 crores in FY26, with management targeting mid-20s ROCE and 3-4 year payback on the capex. For this to hold, tire demand must sustain, with ATMA reporting Q1 FY27 volume growth of 26.6% in passenger vehicles and 16.5% in two-wheelers against an industry capex pipeline of INR25,000 crores, and zinc dross supply must stay uninterrupted despite the ongoing geopolitical conflict. The kill shot is the Dahej ramp itself: the timeline has already slipped once from H1 FY27 to Q3 FY27, and every 10 percentage points of utilization shortfall defers roughly INR90 crores of annualized revenue and pushes the margin recovery out. The tension between the slipped timeline and the record-margin quarter resolves as operational timing rather than structural deterioration, since the margin beat came from operating leverage and mix on the existing asset base, not from the delayed plant.
companyname: J.G. Chemicals Limited ticker: JGCHEM sector: Specialty Chemicals / Zinc Chemicals Manufacturing J.G. Chemicals is India's largest zinc oxide manufacturer and the country's largest zinc recycler. Globally it ranks among the top five zinc oxide producers. The company's core business is taking zinc scrap - specifically zinc dross and ash, by-products of steel galvanizing - and converting it into high-purity zinc oxide and other zinc chemicals through a proprietary recycling process. ...
Read the full report →capex, margin expansion
FY27 revenue growth guided at INR900 crores driven by Gujarat plant commissioning; Gujarat plant utilization expected at 35-40% in H2 FY27 and 65-70% by FY28
Guidance downgradedconsistent
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for J.G. Chemicals Limited and 4,900+ companies.
5-day free pass. No card required.